Samuel E. Halpern
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Radiopharmaceutical Chemistry and Applications 39
- Monoclonal and Polyclonal Antibodies Research 22
- Medical Imaging Techniques and Applications 10
-
- Medical Imaging and Pathology Studies 14
- Co-authors
- Phillip L. Hagan (15 shared papers)Richard M. Bartholomew (8 shared papers)Robert Owen Dillman (7 shared papers)James M. Frincke (4 shared papers)William L. Ashburn (16 shared papers)Gary S. David (4 shared papers)Kenneth W. Martin (1 shared paper)J Beauregard (5 shared papers)
- Journals
- Radiology (9 papers)Investigative Radiology (6 papers)European Journal of Nuclear Medicine and Molecular Imaging (5 papers)Nuclear Medicine Communications (3 papers)Psychiatry Research Neuroimaging (2 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Samuel E. Halpern
78 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 117
- Radiology, Nuclear Medicine and Imaging 957
- Oncology 390
- Immunology 185
- Pathology and Forensic Medicine 150
- Pulmonary and Respiratory Medicine 259
Countries citing papers authored by Samuel E. Halpern
This map shows the geographic impact of Samuel E. Halpern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel E. Halpern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel E. Halpern more than expected).
Fields of papers citing papers by Samuel E. Halpern
This network shows the impact of papers produced by Samuel E. Halpern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel E. Halpern. The network helps show where Samuel E. Halpern may publish in the future.
Co-authors
The 25 scholars most cited alongside Samuel E. Halpern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models. | 1983 | 148 |
| 2 | Tumor size: effect on monoclonal antibody uptake in tumor models. | 1986 | 122 |
| 3 | 1999 | 102 | |
| 4 | 1985 | 79 | |
| 5 | Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells. | 1984 | 78 |
| 6 | Carcinoembryonic antigen production, secretion, and kinetics in BALB/c mice and a nude mouse-human tumor model. | 1984 | 72 |
| 7 | In vivo kinetics of radiolabeled monoclonal anti-CEA antibodies in animal models. | 1985 | 64 |
| 8 | Radioimmunotherapy of human B-cell lymphoma with 90Y-conjugated antiidiotype monoclonal antibody. | 1990 | 63 |
| 9 | 1988 | 59 | |
| 10 | Toxicities and side effects associated with intravenous infusions of murine monoclonal antibodies. | 1986 | 53 |
| 11 | "Cold" bone lesions: a newly recognized phenomenon of bone imaging. | 1974 | 48 |
| 12 | 2002 | 46 | |
| 13 | Correlation of ultrasound and colloid scintiscan studies of the normal and diseased liver. | 1973 | 36 |
| 14 | 1994 | 32 | |
| 15 | 1974 | 31 | |
| 16 | Comparative myocardial uptake of intravenously administered radionuclides. | 1974 | 27 |
| 17 | SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice. | 1993 | 24 |
| 18 | Loculation as a contraindication intracavitary 32P-chromic phosphate therapy. | 1975 | 24 |
| 19 | 99m Tc-penicillamine-acetazolamide complex, a new renal scanning agent. | 1972 | 23 |
| 20 | 1996 | 23 |
About Samuel E. Halpern
Samuel E. Halpern is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Neurology, having authored 84 papers that have together received 1.6k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (39 papers), Monoclonal and Polyclonal Antibodies Research (22 papers), Medical Imaging and Pathology Studies (14 papers), Medical Imaging Techniques and Applications (10 papers), Lymphoma Diagnosis and Treatment (6 papers), HER2/EGFR in Cancer Research (5 papers), Pediatric Urology and Nephrology Studies (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (957 citations), Oncology (390 citations), Immunology (185 citations), Pathology and Forensic Medicine (150 citations) and Pulmonary and Respiratory Medicine (259 citations). Samuel E. Halpern has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Phillip L. Hagan, Richard M. Bartholomew, Robert Owen Dillman, James M. Frincke, William L. Ashburn, Gary S. David, Kenneth W. Martin, J Beauregard, Naomi P. Alazraki and David W. C. Yeung. Their work appears in journals such as Radiology, Investigative Radiology, European Journal of Nuclear Medicine and Molecular Imaging, Nuclear Medicine Communications and Psychiatry Research Neuroimaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.